Study met its primary endpoint by achieving statistical significance on one of its two pre-specified co-primary endpoints, ...

Spinal cord stimulation can reduce pain and restore nerve function among patients with diabetic peripheral neuropathy.

Neuralink is in the process of testing its implant, which is intended to help people with spinal cord injuries. The device ...

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...

Daniel Emori, a spinal cord injury patient, who has been bedridden for 22 years, has appealed for urgent assistance.

By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the Johns Hopkins University School of Medicine have developed a novel blood ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, May 28, 2025 (HealthDay News) — A grid of electrodes slapped on a person’s ...

NurExone expects to initiate a Phase 1/2a clinical trial in 2026 (" 2026 SCI Trial ”) marking a major milestone in the advancement of regenerative therapies for central nervous system injuries.

Around 150,000 people are living with the condition in the UK, while a further 7,100 are newly diagnosed each year ...

Spinal cord injury (SCI) is a devastating, debilitating, and life-altering condition that currently lacks a definitive cure or highly effective treatment ...